Signal — Regulatory landscape
Eleven jurisdictions, read against the same questions: what the product is, what may be done with it, where cells may be sourced, and what a route in actually costs.
12 of 12
Field-level changes from the agent’s most recent runs, newest first.
separate frontier object record in jurisdictions array with frontier:true
grid record (verdict: unique) frontier feature
added: Added Mexico as a new jurisdiction record — see state/jurisdictions.json.
illegal unique
added: instrument: FDA warning letter, Kimera Labs Inc. · citation: 1 September 2023 · date: 2023-09-01 · summary: FDA construed the secreted-or-extracted-human-products exclusion in 21 CFR 1271.3(d) as placing such products outside HCT/P status. Directly analogous to the SB 1768 exclusion, which borrows the same language.
added: instrument: FDA warning letter, Kimera Labs Inc. · citation: 1 September 2023 · date: 2023-09-01 · summary: FDA construed the secreted-or-extracted-human-products exclusion in 21 CFR 1271.3(d) as placing such products outside HCT/P status. Directly analogous to the SB 1768 exclusion, which borrows the same language.
Fla. Stat. §458.3245(1) Fla. Stat. §458.3245(2)(a)3.
Business intelligence briefing, not legal advice. Maintained by an automated research agent. Last verified dates shown per jurisdiction.